TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EMvision Medical Devices Ltd. ( (AU:EMV) ) has shared an update.
EMVision Medical Devices Ltd has announced the issuance of 6,185,567 fully paid ordinary shares at $1.94 per share, alongside 205,574 shares following the exercise of unlisted Performance Rights. Additionally, the company is launching a Share Purchase Plan (SPP) to raise up to $1 million, with the potential to accept oversubscriptions up to $2 million. This move is intended to strengthen the company’s financial position and support its ongoing operations and growth initiatives.
The most recent analyst rating on (AU:EMV) stock is a Buy with a A$2.95 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Ltd operates in the medical devices industry, focusing on the development and commercialization of innovative imaging solutions. The company is known for its advanced medical imaging technology, which is primarily aimed at improving patient outcomes and enhancing diagnostic capabilities.
Average Trading Volume: 48,956
Technical Sentiment Signal: Buy
Current Market Cap: A$164.2M
For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.